Minghui Pharmaceutical (hangzhou) Ltd

This study is testing whether an experimental injection called MHB018A can help control the symptoms of chronic thyroid eye disease, a condition that causes eye bulging, double vision, and discomfort. About 150 adults with moderate-to-severe symptoms will receive either the real …

This is an early-stage clinical trial testing a new drug called MHB042C in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping to control the cancer. The study will…

This study is testing whether an experimental injection called MHB018A can reduce eye bulging and inflammation in people with active, moderate-to-severe thyroid eye disease. About 108 participants will receive either the drug or a placebo injection every four weeks for six months…

This study is testing a new drug called MHB036C, given alongside other cancer therapies, in people with advanced lung cancer. The main goals are to find the safest and most effective dose and to see if the combination can help control the cancer. It is an early-stage trial for ad…

This is the first study in people to test a new drug called MHB048C for advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows early signs of helping to control the cancer. The study will enroll about…

This study is testing a combination of two new drugs, MHB036C and MHB039A, for people with advanced breast cancer or other advanced solid tumors that have spread. The main goals are to see if the drug combination is safe, how the body processes it, and if it can shrink or control…

This is an early-stage study testing a new combination of two drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and see if the drugs show any early signs of fighting the can…

This early-stage study is testing a new drug called MHB046C in people with advanced solid tumors that haven't responded to standard treatments. Researchers will first find the safest dose, then see if the drug helps shrink tumors. The study involves about 200 participants and foc…